We use the event study methodology to investigate the share price responses to the formation of 281 partnerships in the biotechnology/pharmaceutical industry over the years 1995-2000. The average stock price response is positive, more so than in previous empirical works, which could be...

We provide estimates of the abnormal stock market returns associated with pharmaceutical firms' announcements of technological and regulatory successes in drug development. On the basis of these estimates, we find empirical support for two key features of technological race models. First, we...

[eng] This article considers the legal conflicts related to intellectual property rights in the pharmaceutical and biotechnology industry. The first part of the paper uses the event study methodology to assess the impact of these conflicts on the market value of the litigants. In the second...

The second French Community Innovation Survey (CIS) indicates that 14% of R&D collaborating firms had to abandon or delay their innovation projects due to difficulties in their partnerships, an outcome which we term "cooperation failures". Controlling for sample selection on the cooperation...

This article studies the location choices of French firms in 17 developing countries. Detailed attention is paid to the role of the patent rights in the host country. On the one hand, the reduction in competition that follows greater patent protection can attract foreign subsidiaries. On the...

This book analyses how foreign direct investors choose their locations, whilst exploring the forces which shape international economic geography. Although these two issues are, to some extent, inter-related, researchers have only recently acknowledged the similarity of economic geography and...

This paper uses a survey of French firms active in R&D to identify the determinants of the trade-off between R&D subcontracting and R&D cooperation. We observe that R&D subcontracting is more likely than R&D cooperation when the partner is chosen on objective criteria, such as prices, quality...

[eng] This paper investigates how licensing between competitors can create significant barriers to competition. Several theoretical models have shown that licensing an innovation to a competitor can facilitate collusion, deter entry by more efficient firms or hinder technological progress. As a...

[eng] Patent and Drugs in Developing Countries. This article surveys the empirical literature on how patents affect access to drugs in developing countries. In the short run, higher prices and lower access rates are very likely, notably for those countries that benefited from a competitive...